KYORIN Holdings, Inc. (4569.T)
JPY 1440.0
(-0.89%)
JPY 1440.0
(-0.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.29 Billion JPY | 5.75% |
| 2022 | 8.96 Billion JPY | 4.11% |
| 2021 | 8.71 Billion JPY | -7.34% |
| 2020 | 9.33 Billion JPY | -12.13% |
| 2019 | 10.71 Billion JPY | -7.78% |
| 2018 | 11.9 Billion JPY | -4.39% |
| 2017 | 12.45 Billion JPY | -10.29% |
| 2016 | 14.03 Billion JPY | -38.83% |
| 2015 | 23.36 Billion JPY | 28.0% |
| 2014 | 17.79 Billion JPY | -13.77% |
| 2013 | 20.82 Billion JPY | -0.4% |
| 2012 | 21.5 Billion JPY | 21.0% |
| 2011 | 17.82 Billion JPY | -10.21% |
| 2010 | 19.85 Billion JPY | 13.47% |
| 2009 | 17.25 Billion JPY | 30.92% |
| 2008 | 9.02 Billion JPY | 16.69% |
| 2007 | 10.44 Billion JPY | -16.48% |
| 2006 | 13.06 Billion JPY | 2.49% |
| 2005 | 12.14 Billion JPY | 27.74% |
| 2004 | 10.48 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.21 Billion JPY | 17.58% |
| 2023 Q1 | 932 Million JPY | 83.1% |
| 2023 Q4 | 2.61 Billion JPY | -40.32% |
| 2023 FY | - JPY | 5.75% |
| 2023 Q3 | 4.37 Billion JPY | 787.02% |
| 2023 Q2 | 493 Million JPY | -47.1% |
| 2022 Q3 | 4.18 Billion JPY | 924.75% |
| 2022 Q4 | 509 Million JPY | -87.83% |
| 2022 Q1 | 798 Million JPY | -61.43% |
| 2022 Q2 | 408 Million JPY | -48.87% |
| 2022 FY | - JPY | 4.11% |
| 2021 Q2 | 794 Million JPY | 267.86% |
| 2021 FY | - JPY | -7.34% |
| 2021 Q3 | 3.24 Billion JPY | 309.07% |
| 2021 Q4 | 2.06 Billion JPY | -36.3% |
| 2021 Q1 | -473 Million JPY | -126.12% |
| 2020 Q1 | 2.28 Billion JPY | -3.06% |
| 2020 Q4 | 1.81 Billion JPY | -36.77% |
| 2020 Q2 | -430 Million JPY | -118.83% |
| 2020 Q3 | 2.86 Billion JPY | 766.05% |
| 2020 FY | - JPY | -12.13% |
| 2019 Q4 | 2.35 Billion JPY | -50.76% |
| 2019 Q1 | 1.84 Billion JPY | -20.88% |
| 2019 Q2 | -725 Million JPY | -139.21% |
| 2019 Q3 | 4.78 Billion JPY | 760.0% |
| 2019 FY | - JPY | -7.78% |
| 2018 Q1 | 1.6 Billion JPY | 43.6% |
| 2018 Q4 | 2.33 Billion JPY | -41.28% |
| 2018 Q2 | 1.59 Billion JPY | -0.62% |
| 2018 Q3 | 3.98 Billion JPY | 149.69% |
| 2018 FY | - JPY | -4.39% |
| 2017 Q1 | 2.81 Billion JPY | -11.18% |
| 2017 Q4 | 1.11 Billion JPY | -82.97% |
| 2017 Q3 | 6.56 Billion JPY | 693.67% |
| 2017 Q2 | -1.1 Billion JPY | -139.31% |
| 2017 FY | - JPY | -10.29% |
| 2016 Q1 | 3.49 Billion JPY | -30.92% |
| 2016 FY | - JPY | -38.83% |
| 2016 Q3 | 3.8 Billion JPY | 758.47% |
| 2016 Q4 | 3.16 Billion JPY | -16.78% |
| 2016 Q2 | 443 Million JPY | -87.31% |
| 2015 FY | - JPY | 28.0% |
| 2015 Q3 | 10.68 Billion JPY | 446.6% |
| 2015 Q2 | 1.95 Billion JPY | -15.55% |
| 2015 Q1 | 2.31 Billion JPY | -46.28% |
| 2015 Q4 | 5.05 Billion JPY | -52.7% |
| 2014 FY | - JPY | -13.77% |
| 2014 Q2 | 1.05 Billion JPY | -72.69% |
| 2014 Q3 | 6.28 Billion JPY | 498.1% |
| 2014 Q4 | 4.3 Billion JPY | -31.45% |
| 2014 Q1 | 3.84 Billion JPY | -10.94% |
| 2013 Q3 | 7.43 Billion JPY | 301.4% |
| 2013 Q4 | 4.32 Billion JPY | -41.86% |
| 2013 Q2 | 1.85 Billion JPY | -60.47% |
| 2013 Q1 | 4.68 Billion JPY | 6.94% |
| 2013 FY | - JPY | -0.4% |
| 2012 Q1 | 4.35 Billion JPY | 48.99% |
| 2012 FY | - JPY | 21.0% |
| 2012 Q4 | 4.38 Billion JPY | -42.97% |
| 2012 Q3 | 7.68 Billion JPY | 232.55% |
| 2012 Q2 | 2.31 Billion JPY | -46.99% |
| 2011 FY | - JPY | -10.21% |
| 2011 Q2 | 989 Million JPY | -77.06% |
| 2011 Q3 | 7.11 Billion JPY | 619.21% |
| 2011 Q4 | 2.92 Billion JPY | -58.88% |
| 2011 Q1 | 4.31 Billion JPY | -30.35% |
| 2010 Q2 | 2.73 Billion JPY | -8.73% |
| 2010 Q1 | 3 Billion JPY | -15.44% |
| 2010 FY | - JPY | 13.47% |
| 2010 Q4 | 6.19 Billion JPY | -22.06% |
| 2010 Q3 | 7.94 Billion JPY | 190.0% |
| 2009 FY | - JPY | 30.92% |
| 2009 Q2 | 2.47 Billion JPY | -39.54% |
| 2009 Q3 | 7.37 Billion JPY | 197.62% |
| 2009 Q4 | 3.54 Billion JPY | -51.9% |
| 2009 Q1 | 4.1 Billion JPY | -17.82% |
| 2008 FY | - JPY | 16.69% |
| 2008 Q3 | 5.16 Billion JPY | 12109.3% |
| 2008 Q4 | 4.98 Billion JPY | -3.39% |
| 2008 Q2 | -43 Million JPY | 0.0% |
| 2007 FY | - JPY | -16.48% |
| 2006 FY | - JPY | 2.49% |
| 2005 FY | - JPY | 27.74% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -71.001% |
| Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 98.823% |
| Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 103.663% |
| Shionogi & Co., Ltd. | 186.7 Billion JPY | 94.485% |
| Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -1703.241% |
| Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 71.629% |
| Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | 16.067% |
| Eisai Co., Ltd. | 103.1 Billion JPY | 90.014% |
| Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -696.288% |
| Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | 43.86% |
| Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -14.744% |
| Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -180.545% |
| Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -633.856% |
| Tsumura & Co. | 30.77 Billion JPY | 66.541% |
| Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | 45.0% |
| Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -95.333% |
| Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | 71.027% |
| Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -49.608% |
| Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | 41.238% |
| Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 374.56% |
| Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -36.317% |
| SymBio Pharmaceuticals Limited | -714 Million JPY | 1542.017% |
| MedRx Co., Ltd | -884.51 Million JPY | 1264.026% |
| Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -85.973% |
| Solasia Pharma K.K. | -635 Million JPY | 1721.417% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 533.712% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -12.365% |
| Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 72.077% |
| Cyfuse Biomedical K.K. | -538.28 Million JPY | 2012.727% |
| Toho Holdings Co., Ltd. | 25.84 Billion JPY | 60.163% |
| Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -101.817% |